A systematic review and meta-analysis assessing adverse event profile and tolerability of nicergoline-Reference-Cited by-同舟云学术

A systematic review and meta-analysis assessing adverse event profile and tolerability of nicergoline

Published:2014-07-30 Issue:7 Volume:4 Page:e005090-e005090
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Fioravanti M.,Nakashima T.,Xu J.,Garg A.

Publisher

BMJ

Subject

General Medicine

Reference44 articles.

1. Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment;Fioravanti;Cochrane Database Syst Rev,2001

2. Modulation of hippocampal ACh release by chronic nicergoline treatment in freely moving young and aged rats;Carfagna;Neurosci Lett,1995

3. Nicergoline: biochemical studies on neuronal metabolism;Carfagna;Funct Neurol,1989

4. Therapeutic use of nicergoline;Winblad;Clin Drug Investig,2008

5. New restrictions on use of medicines containing ergot derivatives. http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/06/WC500144861.pdf

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hybrid virtual screening and molecular dynamics approach for identification of allosteric modulator of EAAT2;Results in Chemistry;2024-10

2. Pharmacological treatments for vascular dementia: a systematic review and Bayesian network meta-analysis;Frontiers in Pharmacology;2024-08-22

3. Cerebral small vessel disease — new ideas about chronic cerebral ischemia;Clinical Medicine (Russian Journal);2024-06-01

4. Diagnosis and treatment of vascular cognitive disorders;The Clinician;2024-01-19

5. NOOTROPICS: A LONG WAY IN HALF A CENTURY;Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії;2023-03-13